In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives.

[1]  P. Paoli,et al.  Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition. , 2014, European journal of medicinal chemistry.

[2]  J. Medina-Franco,et al.  Antihyperglycemic and sub-chronic antidiabetic actions of morolic and moronic acids, in vitro and in silico inhibition of 11β-HSD 1. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  L. Cantley,et al.  Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine Phosphorylation* , 2013, The Journal of Biological Chemistry.

[4]  F. Alarcón-Aguilar,et al.  Discovery of Thiazolidine‐2,4‐Dione/Biphenylcarbonitrile Hybrid as Dual PPAR α/γ Modulator with Antidiabetic Effect: In vitro, In Silico and In Vivo Approaches , 2013, Chemical biology & drug design.

[5]  J. Medina-Franco,et al.  Vasorelaxant activity of some structurally related triterpenic acids from Phoradendron reichenbachianum (Viscaceae) mainly by NO production: ex vivo and in silico studies. , 2012, Fitoterapia.

[6]  J. Medina-Franco,et al.  Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches. , 2011, European journal of medicinal chemistry.

[7]  J. Medina-Franco,et al.  A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition. , 2010, European journal of medicinal chemistry.

[8]  J. C. Sánchez-Salgado,et al.  Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra‐pancreatic glucose regulation , 2008, Diabetes, obesity & metabolism.

[9]  Sheng Zhang,et al.  PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. , 2007, Drug discovery today.

[10]  H. Waldmann,et al.  Inhibitors of protein tyrosine phosphatases: next-generation drugs? , 2005, Angewandte Chemie.

[11]  J. Ermolieff,et al.  Protein tyrosine phosphatase 1B inhibitors for diabetes , 2002, Nature Reviews Drug Discovery.

[12]  D S Lawrence,et al.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. , 1997, Proceedings of the National Academy of Sciences of the United States of America.